| 000 | 01437 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513235319.0 | ||
| 264 | 0 | _c20010607 | |
| 008 | 200106s 0 0 eng d | ||
| 022 | _a0959-8049 | ||
| 024 | 7 |
_a10.1016/s0959-8049(01)00053-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHengge, U R | |
| 245 | 0 | 0 |
_aLong-term chemotherapy of HIV-associated Kaposi's sarcoma with liposomal doxorubicin. _h[electronic resource] |
| 260 |
_bEuropean journal of cancer (Oxford, England : 1990) _cMay 2001 |
||
| 300 |
_a878-83 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article | ||
| 650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _xcomplications |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCD4 Lymphocyte Count |
| 650 | 0 | 4 |
_aDoxorubicin _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Carriers |
| 650 | 0 | 4 | _aHIV-1 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aLiposomes |
| 650 | 0 | 4 | _aLong-Term Care |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aRNA, Viral _xanalysis |
| 650 | 0 | 4 |
_aSarcoma, Kaposi _xcomplications |
| 650 | 0 | 4 | _aSurvival Analysis |
| 700 | 1 | _aEsser, S | |
| 700 | 1 | _aRudel, H P | |
| 700 | 1 | _aGoos, M | |
| 773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 37 _gno. 7 _gp. 878-83 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0959-8049(01)00053-3 _zAvailable from publisher's website |
| 999 |
_c11247622 _d11247622 |
||